Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 3, Pages 482
Publisher
MDPI AG
Online
2020-01-28
DOI
10.3390/molecules25030482
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
- (2019) Kerstin Heurling et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Validation and noninvasive kinetic modeling of [11C]UCB-J PET imaging in mice
- (2019) Daniele Bertoglio et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Positron Emission Tomography in Pediatric Neurodegenerative Disorders
- (2019) Harry T. Chugani PEDIATRIC NEUROLOGY
- CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset
- (2019) Jong-Min Lee et al. CELL
- Alteration of GABAergic neurotransmission in Huntington's disease
- (2018) Maurice Garret et al. CNS Neuroscience & Therapeutics
- TSPO–PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington’s disease: preclinical evidence with the p75NTR ligand LM11A-31
- (2018) Danielle A Simmons et al. HUMAN MOLECULAR GENETICS
- Longitudinal characterization of mGluR5 using11C-ABP688 PET imaging in the Q175 mouse model of Huntington's disease
- (2018) Daniele Bertoglio et al. JOURNAL OF NUCLEAR MEDICINE
- Microglia in neurodegeneration
- (2018) Suzanne Hickman et al. NATURE NEUROSCIENCE
- PET Radioligands for imaging of the PDE10A in human: current status
- (2018) Giulia Boscutti et al. NEUROSCIENCE LETTERS
- [11C]SCH23390 binding to the D1-dopamine receptor in the human brain—a comparison of manual and automated methods for image analysis
- (2018) Per Stenkrona et al. EJNMMI Research
- Targeting the proteostasis network in Huntington’s disease
- (2018) Tânia R. Soares et al. AGEING RESEARCH REVIEWS
- Novel Imaging Biomarkers for Huntington’s Disease and Other Hereditary Choreas
- (2018) Patrik Fazio et al. Current Neurology and Neuroscience Reports
- Insights into GABA A ergic system alteration in Huntington's disease
- (2018) Yi-Ting Hsu et al. Open Biology
- Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases
- (2017) Anne-Claire Dupont et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight
- (2017) Heinz H. Coenen et al. NUCLEAR MEDICINE AND BIOLOGY
- mGluR5 antagonism increases autophagy and prevents disease progression in thezQ175mouse model of Huntington’s disease
- (2017) Khaled S. Abd-Elrahman et al. Science Signaling
- Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
- (2017) Debra A. Kendall et al. Frontiers in Cellular Neuroscience
- mGluR5 antagonism increases autophagy and prevents disease progression in thezQ175mouse model of Huntington’s disease
- (2017) Khaled S. Abd-Elrahman et al. Science Signaling
- Molecular Imaging Markers to Track Huntington’s Disease Pathology
- (2017) Heather Wilson et al. Frontiers in Neurology
- Striatal Neurons Expressing D1 and D2 Receptors are Morphologically Distinct and Differently Affected by Dopamine Denervation in Mice
- (2017) D. Gagnon et al. Scientific Reports
- Current status of PET imaging in Huntington’s disease
- (2016) Gennaro Pagano et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington’s Disease Knock-In Mice
- (2016) João Luís Neto et al. GENETICS
- [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP
- (2016) Maarten Ooms et al. JOURNAL OF NEUROCHEMISTRY
- Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex
- (2016) Jenny Häggkvist et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
- (2016) N. B. Nabulsi et al. JOURNAL OF NUCLEAR MEDICINE
- Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging
- (2016) David S. Russell et al. NEUROLOGY
- Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington’s Disease Knock-In Mice
- (2016) João Luís Neto et al. GENETICS
- Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease
- (2015) Flavia Niccolini et al. BRAIN
- Discovery of Heterocyclic Nonacetamide Synaptic Vesicle Protein 2A (SV2A) Ligands with Single-Digit Nanomolar Potency: Opening Avenues towards the First SV2A Positron Emission Tomography (PET) Ligands
- (2014) Joël Mercier et al. ChemMedChem
- Cross sectional PET study of cerebral adenosine A1 receptors in premanifest and manifest Huntington’s disease
- (2014) Andreas Matusch et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington’s disease
- (2014) Fabiola M Ribeiro et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Automated one-step radiosynthesis of the CB1receptor imaging agent [18F]MK-9470
- (2014) David Thomae et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- In Vivo Assessment and Dosimetry of 2 Novel PDE10A PET Radiotracers in Humans: 18F-MNI-659 and 18F-MNI-654
- (2014) O. Barret et al. JOURNAL OF NUCLEAR MEDICINE
- Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human
- (2014) C. Plisson et al. JOURNAL OF NUCLEAR MEDICINE
- Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
- (2014) Anthony H V Schapira et al. LANCET
- The Phosphodiesterase 10 Positron Emission Tomography Tracer, [18F]MNI-659, as a Novel Biomarker for Early Huntington Disease
- (2014) David S. Russell et al. JAMA Neurology
- Genetics of Huntington Disease
- (2013) S. Mahalingam et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Continuous-flow synthesis of [11C]raclopride, a positron emission tomography radiotracer, on a microfluidic chip
- (2013) Samar Haroun et al. CANADIAN JOURNAL OF CHEMISTRY
- Quantification of 18F-JNJ-42259152, a Novel Phosphodiesterase 10A PET Tracer: Kinetic Modeling and Test-Retest Study in Human Brain
- (2013) K. Van Laere et al. JOURNAL OF NUCLEAR MEDICINE
- PET imaging shows loss of striatal PDE10A in patients with Huntington disease
- (2013) R. Ahmad et al. NEUROLOGY
- Human biodistribution and dosimetry of 18F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging
- (2012) Koen Van Laere et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Huntington’s Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Disease
- (2012) Michelle E. Ehrlich Neurotherapeutics
- In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons
- (2011) Christine DeLorenzo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Synthesis, In Vivo Occupancy, and Radiolabeling of Potent Phosphodiesterase Subtype-10 Inhibitors as Candidates for Positron Emission Tomography Imaging
- (2011) José-Ignacio Andrés et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fully automated and reproducible radiosynthesis of high specific activity [11C]raclopride and [11C]Pittsburgh compound-B using the combination of two commercial synthesizers
- (2011) Vanessa Gómez-Vallejo et al. NUCLEAR MEDICINE COMMUNICATIONS
- Synthesis of [11C]PBR06 and [18F]PBR06 as agents for positron emission tomographic (PET) imaging of the translocator protein (TSPO)
- (2011) Min Wang et al. STEROIDS
- Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration
- (2010) Catarina V. Gomes et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: A multimodal imaging study
- (2010) Marios Politis et al. HUMAN BRAIN MAPPING
- Extrastriatal dopamine D2receptor binding in Huntington's disease
- (2010) Mouna Esmaeilzadeh et al. HUMAN BRAIN MAPPING
- Metabotropic Glutamate Receptor-Mediated Cell Signaling Pathways Are Altered in a Mouse Model of Huntington's Disease
- (2010) F. M. Ribeiro et al. JOURNAL OF NEUROSCIENCE
- Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo
- (2010) K. Van Laere et al. JOURNAL OF NUCLEAR MEDICINE
- Single-Step High-Yield Radiosynthesis and Evaluation of a Sensitive18F-Labeled Ligand for Imaging Brain Peripheral Benzodiazepine Receptors with PET
- (2009) Emmanuelle Briard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biodistribution and Radiation Dosimetry in Humans of a New PET Ligand, 18F-PBR06, to Image Translocator Protein (18 kDa)
- (2009) Y. Fujimura et al. JOURNAL OF NUCLEAR MEDICINE
- Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers
- (2009) Nicola Pavese et al. NEUROBIOLOGY OF DISEASE
- In vivo imaging of microglial activation using a peripheral benzodiazepine receptor ligand: [11C]PK-11195 and animal PET following ethanol injury in rat striatum
- (2008) Hiroshi Toyama et al. ANNALS OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More